Investigating The Use Of Fostamatinib In Itp

Investigating the Use of Fostamatinib in ITP

Dr. Fertrin on the Potential of Fostamatinib in Chronic ITP

Fostamatinib and efgartigimod: novel agents in the treatment of ITP

VJHemOnc – Video Journal of Hematology & HemOnc

Fostamatinib as Second-Line ITP Therapy

Treating Persistent/Chronic ITP Current Care, Future Potential

ISTH

Michael Boxer, MD, on the effectiveness of fostamatinib in the maintenance of ITP responses

Novel investigational drugs and promising therapies for immune thrombocytopenia

VJHemOnc – Video Journal of Hematology & HemOnc

Potential Role of Syk Inhibitors in ITP

Long-term safety and efficacy of sutimlimab for chronic ITP

VJHemOnc – Video Journal of Hematology & HemOnc

Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia...

Research To Practice

🚩 Common Mistakes to Avoid When Navigating SSDI with Chronic Thrombocytopenia! 🚫

Disability Advantage Group

Dr.Gobind Rai Garg discusses the topic - Fostamatinib

Dr. Gobind Rai Garg

Michael Boxer, MD, considers broader uses for fostamatinib

A Case of Immune Thrombocytopenia

Targeted Oncology

Modern Management of ITP: Thinking Beyond the Conventional Therapies

Thrombocytopenia: Medical Surgical SHORT | @LevelUpRN

Risk of Thrombosis in Patients With ITP

Choosing New Agents for ITP

ASH Clinical Practice Guidelines on Immune Thrombocytopenia (ITP)

American Society of Hematology

Key Insights: Real-World Evidence for ITP Treatment